BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23898070)

  • 41. Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro.
    Banerjee J; Al-Wadei HA; Al-Wadei MH; Dagnon K; Schuller HM
    BMC Cancer; 2014 Sep; 14():725. PubMed ID: 25260978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
    Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
    J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.
    Nawata J; Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Baron B; Akada J; Suenaga S; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Sep; 34(9):4807-11. PubMed ID: 25202061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
    An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
    Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.
    Ina S; Hirono S; Noda T; Yamaue H
    Pancreas; 2010 May; 39(4):473-85. PubMed ID: 19959962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.
    Hong SP; Wen J; Bang S; Park S; Song SY
    Int J Cancer; 2009 Nov; 125(10):2323-31. PubMed ID: 19598259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
    PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas.
    Yang D; Shi J; Fu H; Wei Z; Xu J; Hu Z; Zhang Y; Yan R; Cai Q
    Tumour Biol; 2016 Sep; 37(9):12315-12327. PubMed ID: 27289231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.
    Takano S; Togawa A; Yoshitomi H; Shida T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Tomonaga T; Nomura F; Miyazaki M
    Ann Surg Oncol; 2008 Nov; 15(11):3157-68. PubMed ID: 18712570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p8 is a new target of gemcitabine in pancreatic cancer cells.
    Giroux V; Malicet C; Barthet M; Gironella M; Archange C; Dagorn JC; Vasseur S; Iovanna JL
    Clin Cancer Res; 2006 Jan; 12(1):235-41. PubMed ID: 16397047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer.
    de Sousa Cavalcante L; Monteiro G
    Eur J Pharmacol; 2014 Oct; 741():8-16. PubMed ID: 25084222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.
    Maity G; Ghosh A; Gupta V; Haque I; Sarkar S; Das A; Dhar K; Bhavanasi S; Gunewardena SS; Von Hoff DD; Mallik S; Kambhampati S; Banerjee SK; Banerjee S
    Mol Cancer Ther; 2019 Apr; 18(4):788-800. PubMed ID: 30787177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
    Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20.
    Yao J; Li Z; Wang X; Xu P; Zhao L; Qian J
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):202-8. PubMed ID: 26758190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.
    Hagmann W; Jesnowski R; Löhr JM
    Neoplasia; 2010 Sep; 12(9):740-7. PubMed ID: 20824050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression.
    Tang K; Zhang Z; Bai Z; Ma X; Guo W; Wang Y
    Oncol Rep; 2011 Apr; 25(4):963-70. PubMed ID: 21225236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.
    Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR
    Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
    Xavier CPR; Castro I; Caires HR; Ferreira D; Cavadas B; Pereira L; Santos LL; Oliveira MJ; Vasconcelos MH
    Cancer Lett; 2021 Mar; 501():210-223. PubMed ID: 33212158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
    Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
    Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
    Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.